Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

Afsaneh Shirani; Anne H. Cross; Olaf Stuve

doi:10.1177/17562864241276848

Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

Afsaneh Shirani, Anne H. Cross, Olaf Stuve

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Therapeutic Advances in Neurological Disorders
Volume	17
DOIs	https://doi.org/10.1177/17562864241276848
State	Published - Jan 1 2024

Access to Document

10.1177/17562864241276848

Cite this

@article{25c6b15199644885bc20c8ab17949605,

title = "Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database",

author = "Afsaneh Shirani and Cross, {Anne H.} and Olaf Stuve",

year = "2024",

month = jan,

day = "1",

doi = "10.1177/17562864241276848",

language = "English",

volume = "17",

journal = "Therapeutic Advances in Neurological Disorders",

issn = "1756-2856",

}

Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database. / Shirani, Afsaneh; Cross, Anne H.; Stuve, Olaf.
In: Therapeutic Advances in Neurological Disorders, Vol. 17, 01.01.2024.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Author response to Comment on

T2 - Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

AU - Shirani, Afsaneh

AU - Cross, Anne H.

AU - Stuve, Olaf

PY - 2024/1/1

Y1 - 2024/1/1

UR - http://www.scopus.com/inward/record.url?scp=85204731684&partnerID=8YFLogxK

U2 - 10.1177/17562864241276848

DO - 10.1177/17562864241276848

M3 - Letter

C2 - 39314262

AN - SCOPUS:85204731684

SN - 1756-2856

VL - 17

JO - Therapeutic Advances in Neurological Disorders

JF - Therapeutic Advances in Neurological Disorders

ER -

Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

Access to Document

Other files and links

Cite this